The Impact of Clinical Pharmacist in the Identification and Management of Treatment Related Problems in the Surgery Ward
2021年6月25日 更新者：Hiba Al Fahmawi、University of Jordan
Patients in the surgery ward are at risk of morbidity and mortality from various types of treatment-related problems (TRPs).
The primary aim of this study is to assess the impact of the clinical pharmacist in the identification and management of TRPs in the surgery ward.
研究概览
详细说明
Patients were randomly assigned to intervention (n=50) and usual care (n=50) arms.
The clinical pharmacist assessed the types, frequencies, and clinical significance of TRPs for all recruited patients at baseline.
Patients and treating surgeons in the intervention arm received recommendations concerning the identified TRPs, while the usual care arm did not.
The number of TRPs was reevaluated at follow-up.
研究类型
介入性
注册 (实际的)
100
阶段
- 不适用
联系人和位置
本节提供了进行研究的人员的详细联系信息，以及有关进行该研究的地点的信息。
学习地点
-
-
-
Amman、约旦
- University of Jordan
-
-
参与标准
研究人员寻找符合特定描述的人，称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。
资格标准
适合学习的年龄
18年 及以上 (成人、年长者)
接受健康志愿者
不
有资格学习的性别
全部
描述
Inclusion Criteria:
- Admission for elective, urgent, or emergency surgery
- age 18 years or older
- Expected length of stay of 3 days or more in the general surgical ward or the SICU
Exclusion Criteria:
- Pregnancy, breastfeeding, drug or alcohol abuse, active malignancy, or admission for plastic surgery
学习计划
本节提供研究计划的详细信息，包括研究的设计方式和研究的衡量标准。
研究是如何设计的？
设计细节
- 主要用途：治疗
- 分配：随机化
- 介入模型：并行分配
- 屏蔽：无（打开标签）
武器和干预
参与者组/臂 |
干预/治疗 |
|---|---|
|
实验性的：Clinical pharmacist intervention + usual care arm
Patients in the clinical pharmacist intervention + usual care arm received the clinical pharmacist intervention as well as usual care provided by the surgical team
|
clinical pharmacist intervention
|
|
无干预：Usual care arm (Control arm)
Patients in the control arm received usual care by the surgical team without a coordinated contribution from the clinical pharmacist
|
研究衡量的是什么？
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Acceptance rate of clinical pharmacist's recommended interventions
大体时间：19-week
|
(Number of recommendations accepted by surgeons) / (total number of recommendations submitted to surgeons by the clinical pharmacist) *100
|
19-week
|
|
Implementation rate of clinical pharmacist's recommended interventions
大体时间：19-week
|
(Number of recommendations implemented by surgeons and patients) / (total number of recommendations submitted to surgeons and patients by the clinical pharmacist) *100
|
19-week
|
|
The impact of the clinical pharmacist on the identification and management of TRPs in the surgery ward
大体时间：19-week
|
Measured by comparing the means of differences in the number of TRPs identified at baseline and at the time of short-term follow-up in the intervention and usual care groups
|
19-week
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Surgeons' attitudes and satisfaction towards the provided clinical pharmacy services
大体时间：19-week
|
Measured by a self-administered questionnaire
|
19-week
|
合作者和调查者
在这里您可以找到参与这项研究的人员和组织。
调查人员
- 研究主任：Hiba I. Al Fahmawi, PharmD, MSc、School of Pharmacy, The University of Jordan, Amman, Jordan
出版物和有用的链接
负责输入研究信息的人员自愿提供这些出版物。这些可能与研究有关。
一般刊物
- AbuRuz SM, Bulatova NR, Yousef AM. Validation of a comprehensive classification tool for treatment-related problems. Pharm World Sci. 2006 Aug;28(4):222-32. doi: 10.1007/s11096-006-9048-0. Epub 2006 Oct 26.
- Basheti IA, Ayasrah SM, Ahmad M. Identifying treatment related problems and associated factors among hospitalized post-stroke patients through medication management review: A multi-center study. Saudi Pharm J. 2019 Feb;27(2):208-219. doi: 10.1016/j.jsps.2018.10.005. Epub 2018 Oct 19.
- Bilal AI, Tilahun Z, Beedemariam G, Ayalneh B, Hailemeskel B, Engidawork E. Attitude and satisfaction of health care providers towards clinical pharmacy services in Ethiopia: A post-deployment survey. J Pharm Policy Pract. 2016 Mar 8;9:7. doi: 10.1186/s40545-016-0058-6. eCollection 2016.
- Hepler CD. Clinical pharmacy, pharmaceutical care, and the quality of drug therapy. Pharmacotherapy. 2004 Nov;24(11):1491-8. doi: 10.1592/phco.24.16.1491.50950.
研究记录日期
这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查，以确保它们在发布到公共网站之前符合特定的质量控制标准。
研究主要日期
学习开始 (实际的)
2019年9月29日
初级完成 (实际的)
2020年2月6日
研究完成 (实际的)
2020年2月6日
研究注册日期
首次提交
2021年6月8日
首先提交符合 QC 标准的
2021年6月25日
首次发布 (实际的)
2021年6月28日
研究记录更新
最后更新发布 (实际的)
2021年6月28日
上次提交的符合 QC 标准的更新
2021年6月25日
最后验证
2021年6月1日
更多信息
与本研究相关的术语
其他研究编号
- 80/2019/1943
计划个人参与者数据 (IPD)
计划共享个人参与者数据 (IPD)？
不
IPD 计划说明
The data that support the findings of this study are available on request from the corresponding author.
The data are not publicly available due to privacy or ethical restrictions.
药物和器械信息、研究文件
研究美国 FDA 监管的药品
不
研究美国 FDA 监管的设备产品
不
此信息直接从 clinicaltrials.gov 网站检索，没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求，请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改，我们的网站上也会自动更新.
clinical pharmacist intervention的临床试验
-
Beth Israel Deaconess Medical CenterBrigham and Women's Hospital; Clinical Innovations, LLC招聘中
-
Royal Brompton & Harefield NHS Foundation TrustMedical Research Council; The Hillingdon Hospitals NHS Foundation Trust终止
-
University of Illinois at ChicagoShirley Ryan AbilityLab; Oakland University; Access Living主动，不招人
-
University of Wisconsin, MadisonNational Cancer Institute (NCI); Northwestern University主动，不招人
-
Jaeb Center for Health ResearchJDRF Artificial Pancreas Project完全的
-
University of NottinghamEnhanced Recovery After Surgery Group (part of ESPEN)完全的